Logo
shashi23 @shashi23
Biosimilars Market Size to Surpass US$ 102.69 Billion by 2030 – IMR Reports

Global Biosimilars Market Size Was Valued at USD 36 Billion in 2022, and is Projected to Reach USD 102.69 Billion by 2030, Growing at a CAGR of 14% From 2023-2030.

The Biosimilars Market refers to the segment of the pharmaceutical industry focused on the development, manufacturing, and commercialization of biosimilar products. Biosimilars are biologic drugs that are highly similar to and have no clinically meaningful differences from an existing FDA-approved reference biologic product. These products are developed to be affordable alternatives to branded biologic drugs, offering comparable safety, efficacy, and quality while providing cost savings to healthcare systems, patients, and payers. The market encompasses a wide range of biosimilar products, including monoclonal antibodies, insulin, erythropoietin, growth factors, and other biologic therapeutics used in the treatment of various diseases and medical conditions.

Request A Free Sample Of Biosimilars Market Report Here: https://introspectivemarke...
8 months ago

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from shashi23 , click on at the bottom under it